Clough Capital Partners’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,057,124	Closed	-$4.11M	–	138
2019 Q3	$4.11M	Sell	2,057,124 -27,700	-1%	-$56.1K	0.43%	56
2019 Q2	$4.5M	Sell	2,084,824 -26,400	-1%	-$67.5K	0.44%	70
2019 Q1	$6.67M	Sell	2,111,224 -261,000	-11%	-$844K	0.58%	62
2018 Q4	$5.91M	Buy	2,372,224 +232,930	+11%	+$775K	0.69%	56
2018 Q3	$8.6M	Buy	2,139,294 +77,031	+4%	+$340K	0.81%	45
2018 Q2	$7.79M	Sell	2,062,263 -13,400	-0.6%	-$35K	0.7%	48
2018 Q1	$4.82M	Sell	2,075,663 -591,922	-22%	-$936K	0.46%	62
2017 Q4	$4.13M	Sell	2,667,585 -211,400	-7%	-$340K	0.34%	69
2017 Q3	$6.13M	Hold	2,878,985	–	–	0.41%	63
2017 Q2	$13M	Sell	2,878,985 -79,430	-3%	-$288K	0.9%	36
2017 Q1	$8.9M	Sell	2,958,415 -102,649	-3%	-$303K	0.57%	55
2016 Q4	$8.45M	Hold	3,061,064	–	–	0.56%	57
2016 Q3	$9.58M	Buy	3,061,064 +1,000,000	+49%	+$3.65M	0.5%	70
2016 Q2	$10.6M	Buy	2,061,064 +16,411	+0.8%	+$78.9K	0.56%	63
2016 Q1	$8.36M	Buy	2,044,653 +306,300	+18%	+$1.64M	0.39%	77
2015 Q4	$14.1M	Buy	1,738,353 +154,270	+10%	+$1.29M	0.66%	51
2015 Q3	$13.4M	Buy	1,584,083 +796,500	+101%	+$7.34M	0.58%	59
2015 Q2	$7.41M	Buy	787,583 +190,400	+32%	+$1.77M	0.28%	94
2015 Q1	$5.53M	Buy	597,183 +84,650	+17%	+$811K	0.18%	128
2014 Q4	$4.74M	Buy	512,533 +13,529	+3%	+$114K	0.17%	125
2014 Q3	$4.46M	Buy	499,004 +138,283	+38%	+$1.01M	0.17%	120
2014 Q2	$2.83M	Buy	+360,721	New	+$2.72M	0.09%	149

Other funds holding CORV